Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 143,432 shares at $21.29 ($3.0M) on 2021-08-16, disclosed to the SEC on 2021-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.29 | 42,785 | $911K | 29.9% |
| 2 | $21.29 | 42,785 | $911K | 29.9% |
| 3 | $21.94 | 5,382 | $118K | 3.9% |
| 4 | $21.94 | 5,382 | $118K | 3.9% |
| 5 | $20.89 | 23,549 | $492K | 16.2% |
| 6 | $20.89 | 23,549 |
| $492K |
| 16.2% |
| Total | $21.21 avg | 143,432 | $3.0M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-01 | $4.3M | — | Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2020-05-21 | $1.6M | — | Filing → |